Company Filing History:
Years Active: 1998-2002
Title: Jana Seymour Ulmer: Innovator in Biopharmaceuticals
Introduction
Jana Seymour Ulmer is a prominent inventor based in San Rafael, CA (US). She has made significant contributions to the field of biopharmaceuticals, holding a total of 4 patents. Her work focuses on developing innovative solutions that address critical medical needs.
Latest Patents
Among her latest patents is a groundbreaking invention related to human DNase I variants. This invention pertains to amino acid sequence variants of human DNase I that exhibit reduced binding affinity for actin. The invention provides nucleic acid sequences encoding these actin-resistant variants, enabling their production in quantities sufficient for clinical use. Additionally, she has developed pharmaceutical compositions containing ecotin and homologs thereof. This potent serine protease inhibitor is capable of inhibiting Factor Xa, Factor XIIa, plasma kallikrein, and human leukocyte elastase, making it valuable for treating diseases where such inhibition is indicated.
Career Highlights
Jana is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. Her work at Genentech has allowed her to contribute to advancements in therapeutic solutions that improve patient outcomes.
Collaborations
Throughout her career, Jana has collaborated with notable professionals in her field, including Robert A. Lazarus and Mark S. Dennis. These collaborations have further enriched her research and development efforts, leading to impactful innovations.
Conclusion
Jana Seymour Ulmer stands out as a key figure in the biopharmaceutical industry, with her inventions paving the way for new therapeutic options. Her dedication to innovation continues to inspire advancements in medical science.